278 related articles for article (PubMed ID: 24607566)
21. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
Darrah E; Rosen A; Giles JT; Andrade F
Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
[TBL] [Abstract][Full Text] [Related]
22. Peptidylarginine deiminase is involved in maintaining the cornified oral mucosa of rats.
Arita S; Hatta M; Uchida K; Kita T; Okamura K; Ryu T; Murakami H; Sakagami R; Yamazaki J
J Periodontal Res; 2018 Oct; 53(5):750-761. PubMed ID: 29687476
[TBL] [Abstract][Full Text] [Related]
23. Cellular Activity of New Small Molecule Protein Arginine Deiminase 3 (PAD3) Inhibitors.
Jamali H; Khan HA; Tjin CC; Ellman JA
ACS Med Chem Lett; 2016 Sep; 7(9):847-51. PubMed ID: 27660689
[TBL] [Abstract][Full Text] [Related]
24. Deimination in epidermal barrier and hair formation.
Méchin MC; Simon M
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220245. PubMed ID: 37778378
[TBL] [Abstract][Full Text] [Related]
25. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
[TBL] [Abstract][Full Text] [Related]
26. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
Loos T; Mortier A; Gouwy M; Ronsse I; Put W; Lenaerts JP; Van Damme J; Proost P
Blood; 2008 Oct; 112(7):2648-56. PubMed ID: 18645041
[TBL] [Abstract][Full Text] [Related]
27. Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration.
Jang B; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
Prion; 2013; 7(1):42-6. PubMed ID: 23022892
[TBL] [Abstract][Full Text] [Related]
28. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system.
Musse AA; Li Z; Ackerley CA; Bienzle D; Lei H; Poma R; Harauz G; Moscarello MA; Mastronardi FG
Dis Model Mech; 2008; 1(4-5):229-40. PubMed ID: 19093029
[TBL] [Abstract][Full Text] [Related]
29. Specific citrullination causes assembly of a globular S100A3 homotetramer: a putative Ca2+ modulator matures human hair cuticle.
Kizawa K; Takahara H; Troxler H; Kleinert P; Mochida U; Heizmann CW
J Biol Chem; 2008 Feb; 283(8):5004-13. PubMed ID: 18083705
[TBL] [Abstract][Full Text] [Related]
30. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
31. Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain.
Shimada N; Handa S; Uchida Y; Fukuda M; Maruyama N; Asaga H; Choi EK; Lee J; Ishigami A
J Neurosci Res; 2010 Mar; 88(4):798-806. PubMed ID: 19830834
[TBL] [Abstract][Full Text] [Related]
32. GnRH Stimulates Peptidylarginine Deiminase Catalyzed Histone Citrullination in Gonadotrope Cells.
Khan SA; Edwards BS; Muth A; Thompson PR; Cherrington BD; Navratil AM
Mol Endocrinol; 2016 Oct; 30(10):1081-1091. PubMed ID: 27603413
[TBL] [Abstract][Full Text] [Related]
33. Dynamic expression of peptidylarginine deiminase 2 in human monocytic leukaemia THP-1 cells during macrophage differentiation.
Hojo-Nakashima I; Sato R; Nakashima K; Hagiwara T; Yamada M
J Biochem; 2009 Oct; 146(4):471-9. PubMed ID: 19564157
[TBL] [Abstract][Full Text] [Related]
34. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
[TBL] [Abstract][Full Text] [Related]
35. Activation of Peptidylarginine Deiminase in the Salivary Glands of
Rodríguez-Rodríguez M; Herrera-Esparza R; Bollain Y Goytia JJ; Pérez-Pérez ME; Pacheco-Tovar D; Murillo-Vázquez J; Pacheco-Tovar G; Avalos-Díaz E
J Immunol Res; 2017; 2017():8959687. PubMed ID: 29318161
[TBL] [Abstract][Full Text] [Related]
36. Long-range enhancer associated with chromatin looping allows AP-1 regulation of the peptidylarginine deiminase 3 gene in differentiated keratinocyte.
Chavanas S; Adoue V; Méchin MC; Ying S; Dong S; Duplan H; Charveron M; Takahara H; Serre G; Simon M
PLoS One; 2008; 3(10):e3408. PubMed ID: 18923650
[TBL] [Abstract][Full Text] [Related]
37. Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury.
Piao CS; Loane DJ; Stoica BA; Li S; Hanscom M; Cabatbat R; Blomgren K; Faden AI
Neurobiol Dis; 2012 Jun; 46(3):745-58. PubMed ID: 22426396
[TBL] [Abstract][Full Text] [Related]
38. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
39. Peptidylarginine deiminases and deiminated proteins at the epidermal barrier.
Cau L; Méchin MC; Simon M
Exp Dermatol; 2018 Aug; 27(8):852-858. PubMed ID: 29756256
[TBL] [Abstract][Full Text] [Related]
40. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation.
Zhang X; Bolt M; Guertin MJ; Chen W; Zhang S; Cherrington BD; Slade DJ; Dreyton CJ; Subramanian V; Bicker KL; Thompson PR; Mancini MA; Lis JT; Coonrod SA
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13331-6. PubMed ID: 22853951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
